Spatiotemporal PET imaging of dynamic metabolic changes after therapeutic approaches of induced pluripotent stem cells, neuronal stem cells, and a Chinese patent medicine in stroke

Journal of Nuclear Medicine

Volumn 56, Issue 11, 2015, Pages 1774-1779

  Zhang, Hong ^a   Song, Fahuan ^a   Xu, Caiyun ^a   Liu, Hao ^a   Wang, Zefeng ^a   Li, Jinhui ^a   Wu, Shuang ^a   Shen, Yehua ^a   Chen, Yao ^a   Zhu, Yunqi ^a   Du, Ruili ^a   Tian, Mei ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Induced pluripotent stem cell (iPSC); Middle cerebral artery occlusion (MCAO); Neuronal stem cell (NSC); Positron emission tomography (PET); Qing kai ling (QKL)

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; PLANT MEDICINAL PRODUCT; QING KAI LING; UNCLASSIFIED DRUG; HERBACEOUS AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN METABOLISM; CELL MIGRATION; CELL SURVIVAL; CHINESE MEDICINE; CONTROLLED STUDY; INDUCED PLURIPOTENT STEM CELL TRANSPLANTATION; MALE; MOUSE; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PET SCANNER; PLURIPOTENT STEM CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; STEM CELL TRANSPLANTATION; ANIMAL; ASIAN CONTINENTAL ANCESTRY GROUP; AUTORADIOGRAPHY; CEREBROVASCULAR DISORDERS; CHINA; HUMAN; INFARCTION, MIDDLE CEREBRAL ARTERY; MULTIMODALITY CANCER THERAPY; NEURAL STEM CELL; PROCEDURES; PSYCHOMOTOR PERFORMANCE; SCINTISCANNING; STROKE; TREATMENT OUTCOME;

ANIMALS; ASIAN CONTINENTAL ANCESTRY GROUP; AUTORADIOGRAPHY; CEREBROVASCULAR DISORDERS; CHINA; COMBINED MODALITY THERAPY; DRUGS, CHINESE HERBAL; FLUORODEOXYGLUCOSE F18; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEURAL STEM CELLS; POSITRON-EMISSION TOMOGRAPHY; PSYCHOMOTOR PERFORMANCE; RADIOPHARMACEUTICALS; RATS; REPERFUSION INJURY; STEM CELL TRANSPLANTATION; STROKE; TREATMENT OUTCOME;

EID: 84946571957     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.115.163170     Document Type: Article

References (34)

1. Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383:245-254.
2. Fisher M. New approaches to neuroprotective drug development. Stroke. 2011;42: S24-S27.
3. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 2003;4:399-415.
4. Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. Lancet. 2011;377: 1693-1702.
5. Kalladka D, Muir KW. Brain repair: cell therapy in stroke. Stem Cells Cloning. 2014;7:31-44.
6. Liu X, Ye R, Yan T, et al. Cell based therapies for ischemic stroke: from basic science to bedside. Prog Neurobiol. 2014;115:92-115.
7. Daadi MM, Hu S, Klausner J, et al. Imaging neural stem cell graft-induced structural repair in stroke. Cell Transplant. 2013;22:881-892.
8. Gage FH. Mammalian neural stem cells. Science. 2000;287:1433-1438.
9. 18F-FDG microPET to monitor neural stem cell transplantation in a rat model of traumatic brain injury. Eur J Nucl Med Mol Imaging. 2008;35:1699-1708.
10. Chen SJ, Chang CM, Tsai SK, et al. Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue. Stem Cells Dev. 2010;19:1757-1767.
11. Fan X, Sun D, Tang X, Cai Y, Yin ZQ, Xu H. Stem-cell challenges in the treatment of Alzheimer's disease: a long way from bench to bedside. Med Res Rev. 2014;34:957-978.
12. Roessler R, Boddeke E, Copray S. Induced pluripotent stem cell technology and direct conversion: new possibilities to study and treat Parkinson's disease. Stem Cell Rev. 2013;9:505-513.
13. Heiss WD. Radionuclide imaging in ischemic stroke. J Nucl Med. 2014;55:1831-1841.
14. Wang Z, Wan H, Li J, Zhang H, Tian M. Molecular imaging in traditional Chinese medicine therapy for neurological diseases. Biomed Res Int. 2013;2013:608430.
15. Cheng F, Zhong X, Lu Y, et al. Refined Qingkailing protects MCAO mice from endoplasmic reticulum stress-induced apoptosis with a broad time window. Evid Based Complement Alternat Med. 2012;2012:567872.
16. Hua Q, Zhu X, Li P, et al. Refined Qing Kai Ling, traditional Chinese medicinal preparation, reduces ischemic stroke-induced infarct size and neurological deficits and increases expression of endothelial nitric oxide synthase. Biol Pharm Bull. 2008;31:633-637.
17. Hua Q, Zhu XL, Li PT, et al. The inhibitory effects of cholalic acid and hyodeoxycholalic acid on the expression of TNF-α and IL-1β after cerebral ischemia in rats. Arch Pharm Res. 2009;32:65-73.
18. Wang J, Tian M, Zhang H. PET molecular imaging in stem cell therapy for neurological diseases. Eur J Nucl Med Mol Imaging. 2011;38:1926-1938.
19. Wang J, Chao F, Han F, et al. PET demonstrates functional recovery after transplantation of induced pluripotent stem cells in a rat model of cerebral ischemic injury. J Nucl Med. 2013;54:785-792.
20. Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats: statistical validation. Stroke. 1995;26:627-634.
21. Lv L, Liu Y, Shi HF, Dong Q. Qingkailing injection attenuates apoptosis and neurologic deficits in a rat model of intracerebral hemorrhage. J Ethnopharmacol. 2009;125:269-273.
22. Palmer TD, Markakis EA, Willhoite AR, Safar F, Gage FH. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J Neurosci. 1999;19:8487-8497.
23. Sugiura S, Kitagawa K, Tanaka S, et al. Adenovirus-mediated gene transfer of heparin-binding epidermal growth factor-like growth factor enhances neurogenesis and angiogenesis after focal cerebral ischemia in rats. Stroke. 2005;36:859-864.
24. Green AR, Shuaib A. Therapeutic strategies for the treatment of stroke. Drug Discov Today. 2006;11:681-693.
25. Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM, Arumugam TV. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener. 2011;6:11.
26. Rosenblum S, Wang N, Smith TN, et al. Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation. Stroke. 2012;43:1624-1631.
27. Oki K, Tatarishvili J, Wood J, et al. Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells. 2012;30:1120-1133.
28. Miljan EA, Sinden JD. Stem cell treatment of ischemic brain injury. Curr Opin Mol Ther. 2009;11:394-403.
29. Yue S, Li Q, Liu S, et al. Mechanism of neuroprotective effect induced by QingKaiLing as an adjuvant drug in rabbits with E. coli bacterial meningitis. Acta Neurochir Suppl. 2006;96:413-418.
30. Tang Y, Wang J, Lin X, et al. Neural stem cell protects aged rat brain from ischemia-reperfusion injury through neurogenesis and angiogenesis. J Cereb Blood Flow Metab. 2014;34:1138-1147.
31. Guzman R, De Los Angeles A, Cheshier S, et al. Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model. Stroke. 2008;39:1300-1306.
32. Duelli R, Kuschinsky W. Brain glucose transporters: relationship to local energy demand. News Physiol Sci. 2001;16:71-76.
33. Yu AS, Hirayama BA, Timbol G, et al. Regional distribution of SGLT activity in rat brain in vivo. Am J Physiol Cell Physiol. 2013;304:C240-C247.
34. Zhao Y, Lai W, Xu Y, Li L, Chen Z, Wu W. Exogenous and endogenous therapeutic effects of combination Sodium Ferulate and bone marrow stromal cells (BMSCs) treatment enhance neurogenesis after rat focal cerebral ischemia. Metab Brain Dis. 2013;28:655-666.